- India has the advantage of the cost, as the cost of labor, the cost of inventory is much lower than other places
- The multinational companies, investing in research and development in India may save upto 30% to 50% of the expenses incurred
- The cost of hiring a research chemist in the US is five times higher than its Indian counterpart
- The manufacturing cost of pharmaceutical products in India is nearly half of the cost incurred in US
- The cost of performing clinical trials in India is one tenth of the cost incurred in US
- The cost of performing research in India is one eighth of the cost incurred in US
|
Top
10 Pharmaceuticals in India, as of 2010
|
|||
|
Rank
|
Company
|
Revenue
2010 (Rs crore)
|
Revenue
2010 (Rs billion)
|
|
1
|
Cipla
|
4,198.96
|
41.989
|
|
2
|
Ranbaxy
|
4,162.25
|
41.622
|
|
3
|
Dr.
Reddy's Laboratories
|
3,763.72
|
37.637
|
|
4
|
Sun
Pharmaceutical
|
2,463.59
|
24.635
|
|
5
|
Lupin
Ltd
|
2,215.52
|
22.155
|
|
6
|
Aurobindo
Pharma
|
2,081.19
|
20.801
|
|
7
|
GlaxoSmithKline
|
1,773.41
|
17.734
|
|
8
|
Cadila
Healthcare
|
1,613
|
16.13
|
|
9
|
Aventis
Pharma
|
983.80
|
9.838
|
|
10
|
Ipca
Laboratories
|
980.44
|
9.8044
|
Top 10 therapeutic segments in India
by market value and growth
As per
the data available from express pharma online 2008, anti-infective has led the
market with market size of Rs. 4973.1 crore and this market is the expected to
grow 14.0% during FY 2008 to FY 2013. However, gastro intestinal market has
stood at 2nd position following anti-infective with value of Rs.
3500 crore and it is expected to grow with 14% during FY 2008 to FY 2013. Other
markets like cardiovascular ranked 3rd with value of Rs.3480 crore
followed by respiratory, analgesics, nutrients and vitamins, gynecology,
neurology, dermatology, anti-diabetic and others.
Indian
domestic formulation by Therapeutic category (FY 2008)
|
Sr. No.
|
Therapeutic category
|
Market size (in crores)
|
Expected growth 2008-2013
|
|
1
|
Anti-infective
|
4973.1
|
14%
|
|
2
|
Gastro intestinal
|
3500
|
14%
|
|
3
|
Cardiovascular
|
3480
|
15.90%
|
|
4
|
Respiratory
|
2880
|
10.40%
|
|
5
|
Analgesics
|
2840
|
7.40%
|
|
6
|
vitamins
|
2530
|
8.80%
|
|
7
|
gynaecology
|
1810
|
14%
|
|
8
|
Neurology
|
1760
|
12.40%
|
|
9
|
Dermatology
|
1750
|
12.40%
|
|
10
|
Anti-diabetic
|
1600
|
18.80%
|
|
Source: Express Pharma online
|
|||
No comments:
Post a Comment